Drug nanoparticles – a common approach to tackle the poor aqueous solubility of APIs

Nanosizing drug particles brings key benefits for oral formulations of poorly soluble drugs such as Biopharmaceutics Classification System (BCS) Class II drugs.

8 supercritical companies inspired by Michel Perrut, founder of SEPAREX

SEPAREX, the gold standard in supercritical fluids, was founded in 1985 by Michel Perrut.

SEPAREX was also a pioneering business incubator, far ahead of its time, contributing to the birth of 8 companies.